Validation for performing 11C-methionine and 18F-FDG-PET studies on the same day

Nuclear Medicine Communications

Volumn 33, Issue 3, 2012, Pages 297-304

  Mitsumoto, Takuya ^a,c   Kubota, Kazuo ^a   Sato, Takashi ^a   Morooka, Miyako ^a   Minamimoto, Ryogo ^a   Shimbo, Takuro ^b   Muramatsu, Yoshihisa ^a   Sasaki, Toru ^a   Ito, Kimiteru ^d   Fukushi, Masahiro ^c  

^a Department of Radiology ^*  (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c TOKYO METROPOLITAN UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

dual tracers; fluoro 2 deoxy D glucose; methionine; PET computed tomography; positron cross talk; quality assurance

Indexed keywords

CARBON 11; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GLUCOSE; METHIONINE C 11; CARBON; DIAGNOSTIC AGENT; METHIONINE; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC VALUE; DRUG HALF LIFE; FEMALE; GLUCOSE BLOOD LEVEL; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; PHANTOM; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; VALIDATION STUDY; AGED; HEAD AND NECK TUMOR; LIVER; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; MIDDLE AGED; MUSCLE; SCINTISCANNING; TIME; TISSUE DISTRIBUTION; WHOLE BODY IMAGING;

AGED; CARBON RADIOISOTOPES; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LIVER; MALE; METABOLIC CLEARANCE RATE; METHIONINE; MIDDLE AGED; MUSCLES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TIME FACTORS; TISSUE DISTRIBUTION; WHOLE BODY IMAGING;

EID: 84856089655     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32834dfa38     Document Type: Article

References (22)

1. Kato T, Shinoda J, Nakayama N, Miwa K, Okumura A, Yano H, et al. Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. AJNR Am J Neuroradiol 2008; 29: 1176-1182. (Pubitemid 351954890)
2. Yamamoto Y, Nishiyama Y, Kimura N, Kameyama R, Kawai N, Hatakeyama T, et al. 11C-acetate PET in the evaluation of brain glioma: comparison with 11C-methionine and 18F-FDG-PET. Mol Imaging Biol 2008; 10: 281-287.
3. Nettelbladt OS, Sundin AE, Valind SO, Gustafsson GR, Lamberg K, Lå ngström B, Björnsson EH. Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum. J Nucl Med 1998; 39: 640-647. (Pubitemid 28175839)
4. Pirotte B, Goldman S, Dewitte O, Massager N, Wikler D, Lefranc F, et al. Integrated positron emission tomography and magnetic resonance imagingguided resection of brain tumors: a report of 103 consecutive procedures. J Neurosurg 2006; 104: 238-253.
5. Kubota K, Yamada S, Ishiwata K, Ito M, Ido T. Positron emission tomography for treatment evaluation and recurrence detection compared with CT in long-term follow-up cases of lung cancer. Clin Nucl Med 1992; 17: 877-881.
6. Jang HW, Choi JY, Lee JI, Kim HK, Shin HW, Shin JH, et al. Localization of medullary thyroid carcinoma after surgery using (11)C-methionine PET/CT: comparison with (18)F-FDG PET/CT. Endocr J 2010; 57: 1045-1054.
7. Dankerl A, Liebisch P, Glatting G, Friesen C, Blumstein NM, Kocot D, et al. Multiple myeloma: molecular imaging with 11C-methionine PET/CT-initial experience. Radiology 2007; 242: 498-508. (Pubitemid 46146203)
8. Morooka M, Kubota K, Kadowaki H, Ito K, Okazaki O, Kashida M, et al. 11C-methionine PET of acute myocardial infarction. J Nucl Med 2009; 50: 1283-1287.
9. Nuñ ez R, Macapinlac HA, Yeung HW, Akhurst T, Cai S, Osman I, et al. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer. J Nucl Med 2002; 43: 46-55. (Pubitemid 34101187)
10. Macapinlac HA, Humm JL, Akhurst T, Osman I, Pentlow K, Shangde C, et al. Differential metabolism and pharmacokinetics of L-[1-11C]-methionine and 2-[18F] fluoro-2-deoxy-D-glucose (FDG) in androgen independent prostate cancer. Clin Positron Imaging 1999; 2: 173-181.
11. Inoue T, Kim EE, Wong FC, Yang DJ, Bassa P, Wong WH, et al. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors. J Nucl Med 1996; 37: 1472-1476. (Pubitemid 26321625)
12. Kanegae K, Nakano I, Kimura K, Kaji H, Kuge Y, Shiga T, et al. Comparison MET-PET for differentiation between benign lesion and lung cancer in pneumoconiosis. Ann Nucl Med 2007; 21: 331-337. (Pubitemid 47283261)
13. Deloar HM, Fujiwara T, Nakamura T, Itoh M, Imai D, Miyake M, Watanuki S. Estimation of internal absorbed dose of L-[methyl-11C] methionine using whole-body positron emission tomography. Eur J Nucl Med 1998; 25: 629-633. (Pubitemid 28297838)
14. Leskinen-Kallio S, Nå gren K, Lehikoinen P, Ruotsalainen U, Joensuu H. Uptake of 11C-methionine in breast cancer studied by PET. An association with the size of S-phase fraction. Br J Cancer 1991; 64: 1121-1124.
15. Ikoma Y, Toyama H, Suhara T. Simultaneous quantification of two brain functions with dual tracer injection in PET dynamic study. Int Congress Ser 2004; 1265: 74-78.
16. Ikoma Y, Watabe H, Hayashi T, Miyake Y, Teramoto N, Minato K, Iida H. Measurement of density and affinity for dopamine D2 receptors by a single positron emission tomography scan with multiple injections of [11C] raclopride. J Cereb Blood Flow Metab 2010; 30: 663-673.
17. Kubota K, Matsuzawa T, Ito M, Ito K, Fujiwara T, Abe Y, et al. Lung tumor imaging by positron emission tomography using C-11L-methionine. J Nucl Med 1985; 26: 37-42. (Pubitemid 15161421)
18. Kamimura K, Nagamachi S, Wakamatsu H, Higashi R, Ogita M, Ueno S, et al. Associations between liver 18F fluoro-2-deoxy-D-glucose accumulation and various clinical parameters in a Japanese population: influence of the metabolic syndrome. Ann Nucl Med 2010; 24: 157-161.
19. Yeung HW, Sanches A, Squire OD, Macapinlac HA, Larson SM, Erdi YE. Standardized uptake value in pediatric patients : an investigation to determine the optimum measurement parameter. Eur J Nucl Med Mol Imaging 2002; 29: 61-66. (Pubitemid 34143430)
20. Sugawara Y, Shulkin BL, Zasadny KR, Wahl RL. Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction. Radiology 1999; 213: 521-525. (Pubitemid 29510601)
21. Kubota K, Watanabe H, Murata Y, Yukihiro M, Ito K, Morooka M, et al. Effects of blood glucose level on FDG uptake by liver: a FDG-PET/CT study. Nucl Med Biol 2011; 38: 347-351.
22. Hays MT, Segall GM. A mathematical model for the distribution of fluorodeoxyglucose in humans. J Nucl Med 1999; 40: 1358-1366. (Pubitemid 29385646)